A herb commonly sold in cold and flu supplements may no longer be classified as “low-risk”, after Australia’s therapeutic goods regulator found it can cause severe allergic reactions and even death.
The Therapeutic Goods Administration (TGA) is proposing to remove andographis – widely used in Indian and Chinese traditional medicine – from its list of permitted ingredients. A new safety review found the herb can cause “rapid and unpredictable” anaphylaxis, the most severe type of allergic reaction.
